Starward Vector in this launch trailer for the dice-driven RPG set in a human and heartfelt sci-fi world. You are an escaped android, with a malfunctioning body, a price on your head and no memory of ...

If Intel hopes to survive the next few years as a freestanding company and return to its role as innovator, it can not afford ...

Bring a Trailer sets a new benchmark with $1.5B in auction sales, 45,000 listings, and rapid expansion into international markets.

We didn't want the 50kg monster AMD Behemoth System we built over 3 months getting damaged, so James put the system into his car and drove it to competition winner Cameron. Cameron is a shy guy but we ...

CAR T–focused biotech Cargo Therapeutics surprised and disappointed analysts when it announced that it would discontinue a ...

Citizen Sleeper 2's broader scope stretches its mechanics thin, even while its story flourishes. PC Gamer's got your back Our ...

The long-awaited Alpine A390 electric car from Renault will be a rival to the Tesla Model Y, which is the company's most ...

The changes will extend the company's cash runway, enabling it to advance a tri-specific CAR T-cell candidate and its allogeneic cell therapy platform.

CARGO Therapeutic announced that it has elected to discontinue FIRCE-1, a Phase 2 clinical study of firi-cel for patients with large B-cell lymphoma whose disease relapsed or was refractory to CD19 ...

On January 16, 2025, the US Department of Commerce’s Bureau of Industry and Security (BIS) published a final rule prohibiting the sale or import ...

CARGO elects to discontinue FIRCE-1, a Phase 2 clinical study of firicabtagene autoleucel (firi-cel)1; Company believes results do not support a ...

VectorBuilder's partner, Ucello, announced that its CD19-targeting umbilical cord blood-derived allogeneic CAR-T cell therapy ...